Close Menu

BIO

According to the San Diego Union-Tribune, biotech firms there are beginning to explore issues of diversity in the workforce.

A draft bill provides for a major expansion of eligible material, a move the ACLU and AMP said threatens to reduce competition in genetic testing.

Tell Me, Please

A US senator has sent letters to two biotech and pharmaceutical industry groups to ask about their approaches to handling sexual harassment, according to Stat News.

The Party at Bio Not Associated with Bio included nude or partially nude female dancers, prompting an outcry, BioCentury reports.

Industry reactions to the US Supreme Court's decision to invalidate patents on isolated gene sequences were immediate and ranged from elation to disappointment.

A Supreme Court decision against drug developers in Sorrell v. IMS Health could potentially hamper how pharmacy benefit managers can use physician prescription data to drive adoption of pharmacogenomically guided products.

The Senate may be close to passing the SBIR/STTR reauthorization act, which would boost agency set-asides for SBIR, increase the size of Phase I and Phase II awards, and allow VC-owned firms to apply.

A bi-partisan bill with a broad base of support aims to streamline the system.

Pages

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.